Population Eye Health Through Telemedicine

KYS is a non-profit foundation which is focused on one “vision” – helping everyone else keep theirs! KYS has created the first telemedicine platform for population eye health. Using established clinically validated digital health tools such as the Peristat and Macustat telemedicine tests, KYS empowers doctors, clinics and health centers to offer best-in-class vision screening and testing to patients right from their homes.

The KYS approach is unique – it uses the power of real-time connectivity to solve some of the biggest challenges for any public health initiative – scalability, throughput, universal access and efficiency. By placing cutting edge telemedicine technology in the service of doctors and patients, the KYS Foundation is enabling a new public service paradigm, raising awareness and actively promoting eye health in the community.

KYS is not doing this alone – our public health mission is only possible by working together with doctors and clinics in every community- fighting against preventable blindness in every corner, every neighborhood, every home. Only through active outreach, smart technology, grassroots preventive care and full collaboration and engagement of all eye care professionals can we win against glaucoma, macular degeneration, diabetic eye disease and other sight threatening conditions.

The KYS Foundation History

Two eye doctors – one mission: Keep Your Sight!

The original idea behind KYS and online vision screening started in 2005 when two eye doctors realized that many of their patients were going blind even before they reached the clinic. Despite a busy practice, Dr. Ianchulev and Dr. Pham set out on a mission to solve a problem of public health proportions for both developed and developing countries alike where more than 50% of all glaucoma remains undiagnosed – in the US alone, more than 1.5-2 million people are losing sight to glaucoma without notice.

In 2006, Dr. Ianchulev and Dr. Pham developed the first prototype of the visual field test, called Peristat, which can deliver an online adaptation of the clinical perimetry test used in specialized medical offices. It took years to perfect and improve the technology to allow efficient and streamlined testing. Today, the Peristat test can be taken virtually from any computer or mobile device in less than 5 minutes. Focused on how to improve public health further, Dr. Ianchulev and Dr. Pham added another telemedicine test called Macustat for retinal function testing. Macustat is a 3 minute test for the early detection of retinal problems such as AMD and diabetic retinopathy.

In 2010, Dr. Ianchulev and Dr. Pham started the KYS Foundation to further the work on a larger scale and help millions of people worldwide keep their sight.

In 2020, they updated the platform with new patient and doctor interface and advanced testing platform.

Sean Ianchulev,
MD MPH Co-Founder

Dr. Ianchulev is a world renowned, Harvard-trained ophthalmologist with a dual degree in medicine and public health. Dr. Ianchulev has been on the cutting edge of innovation, making an impact in the treatment of major eye diseases such as macular degeneration and glaucoma. As an inventor and innovator, he was instrumental in the development of many new therapies and advances, such as Lucentis for AMD and Diabetic Retinopathy, intraoperative aberrometry for high-precision cataract surgery, micro-stent technology for glaucoma, the miLOOP interventional technology for cataract surgery and others. Dr. Ianchulev is a Professor of Ophthalmology at the New York Eye and Ear Infirmary of Mount Sinai. 

Dr. Peter Pham
Co-Founder, Board-certified ophthalmologist Peter Pham,
MD, Co-Founder

Dr. Pham is a boarded certified ophthalmologist who has devoted his professional life to restoring sight and helping patients keep their vision. As a surgeon and clinician, Dr. Pham treats blinding conditions such as glaucoma, cataract and macular degeneration. As a researcher, he worked on the development of a novel delivery system for introducing large-sized molecular compounds into thousands of living cells simultaneously. These molecular compounds allowed researchers to trace the molecular process cells use to achieve cellular movement, which is a critical biological task in everything from bone growth to cancer metastasis. Realizing the importance of technology and innovation for screening and prevention, Dr. Pham teamed up with Dr. Ianchulev to develop the KYS telemedicine system for vision health.

Dr. Pham received his medical degree from Washington University School of Medicine in St. Louis after graduating summa cum laude from Washington University with an undergraduate degree in chemistry. He completed his ophthalmology training at the Doheny Eye Institute in Los Angeles. Dr. Pham is the Chief of Surgery at St. Luke’s Hospital at the Vintage and maintains an active ophthalmology practice in the Houston area.

Articles

post 2

[xyz-ips snippet=”Test”]   I love to eat apple pie. I love to eat cherry pie. [xyz-ips snippet=”Test”] [xyz-ips snippet=”referral-codes”]

Read More »